Cargando…

Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)

BACKGROUND: In the context of prostate cancer (PCa) characterized by the multiple alternative treatment strategies, comparative effectiveness analysis is essential for informed decision-making. We analyzed the comparative effectiveness of PCa treatments through systematic review and meta-analysis wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayadevappa, Ravishankar, Chhatre, Sumedha, Wong, Yu-Ning, Wittink, Marsha N., Cook, Ratna, Morales, Knashawn H., Vapiwala, Neha, Newman, Diane K., Guzzo, Thomas, Wein, Alan J., Malkowicz, Stanley B., Lee, David I., Schwartz, Jerome S., Gallo, Joseph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419922/
https://www.ncbi.nlm.nih.gov/pubmed/28471976
http://dx.doi.org/10.1097/MD.0000000000006790
_version_ 1783234300919939072
author Jayadevappa, Ravishankar
Chhatre, Sumedha
Wong, Yu-Ning
Wittink, Marsha N.
Cook, Ratna
Morales, Knashawn H.
Vapiwala, Neha
Newman, Diane K.
Guzzo, Thomas
Wein, Alan J.
Malkowicz, Stanley B.
Lee, David I.
Schwartz, Jerome S.
Gallo, Joseph J.
author_facet Jayadevappa, Ravishankar
Chhatre, Sumedha
Wong, Yu-Ning
Wittink, Marsha N.
Cook, Ratna
Morales, Knashawn H.
Vapiwala, Neha
Newman, Diane K.
Guzzo, Thomas
Wein, Alan J.
Malkowicz, Stanley B.
Lee, David I.
Schwartz, Jerome S.
Gallo, Joseph J.
author_sort Jayadevappa, Ravishankar
collection PubMed
description BACKGROUND: In the context of prostate cancer (PCa) characterized by the multiple alternative treatment strategies, comparative effectiveness analysis is essential for informed decision-making. We analyzed the comparative effectiveness of PCa treatments through systematic review and meta-analysis with a focus on outcomes that matter most to newly diagnosed localized PCa patients. METHODS: We performed a systematic review of literature published in English from 1995 to October 2016. A search strategy was employed using terms “prostate cancer,” “localized,” “outcomes,” “mortality,” “health related quality of life,” and “complications” to identify relevant randomized controlled trials (RCTs), prospective, and retrospective studies. For observational studies, only those adjusting for selection bias using propensity-score or instrumental-variables approaches were included. Multivariable adjusted hazard ratio was used to assess all-cause and disease-specific mortality. Funnel plots were used to assess the level of bias. RESULTS: Our search strategy yielded 58 articles, of which 29 were RCTs, 6 were prospective studies, and 23 were retrospective studies. The studies provided moderate data for the patient-centered outcome of mortality. Radical prostatectomy demonstrated mortality benefit compared to watchful waiting (all-cause HR = 0.63 CI = 0.45, 0.87; disease-specific HR = 0.48 CI = 0.40, 0.58), and radiation therapy (all-cause HR = 0.65 CI = 0.57, 0.74; disease-specific HR = 0.51 CI = 0.40, 0.65). However, we had minimal comparative information about tradeoffs between and within treatment for other patient-centered outcomes in the short and long-term. CONCLUSION: Lack of patient-centered outcomes in comparative effectiveness research in localized PCa is a major hurdle to informed and shared decision-making. More rigorous studies that can integrate patient-centered and intermediate outcomes in addition to mortality are needed.
format Online
Article
Text
id pubmed-5419922
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-54199222017-05-11 Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant) Jayadevappa, Ravishankar Chhatre, Sumedha Wong, Yu-Ning Wittink, Marsha N. Cook, Ratna Morales, Knashawn H. Vapiwala, Neha Newman, Diane K. Guzzo, Thomas Wein, Alan J. Malkowicz, Stanley B. Lee, David I. Schwartz, Jerome S. Gallo, Joseph J. Medicine (Baltimore) 5700 BACKGROUND: In the context of prostate cancer (PCa) characterized by the multiple alternative treatment strategies, comparative effectiveness analysis is essential for informed decision-making. We analyzed the comparative effectiveness of PCa treatments through systematic review and meta-analysis with a focus on outcomes that matter most to newly diagnosed localized PCa patients. METHODS: We performed a systematic review of literature published in English from 1995 to October 2016. A search strategy was employed using terms “prostate cancer,” “localized,” “outcomes,” “mortality,” “health related quality of life,” and “complications” to identify relevant randomized controlled trials (RCTs), prospective, and retrospective studies. For observational studies, only those adjusting for selection bias using propensity-score or instrumental-variables approaches were included. Multivariable adjusted hazard ratio was used to assess all-cause and disease-specific mortality. Funnel plots were used to assess the level of bias. RESULTS: Our search strategy yielded 58 articles, of which 29 were RCTs, 6 were prospective studies, and 23 were retrospective studies. The studies provided moderate data for the patient-centered outcome of mortality. Radical prostatectomy demonstrated mortality benefit compared to watchful waiting (all-cause HR = 0.63 CI = 0.45, 0.87; disease-specific HR = 0.48 CI = 0.40, 0.58), and radiation therapy (all-cause HR = 0.65 CI = 0.57, 0.74; disease-specific HR = 0.51 CI = 0.40, 0.65). However, we had minimal comparative information about tradeoffs between and within treatment for other patient-centered outcomes in the short and long-term. CONCLUSION: Lack of patient-centered outcomes in comparative effectiveness research in localized PCa is a major hurdle to informed and shared decision-making. More rigorous studies that can integrate patient-centered and intermediate outcomes in addition to mortality are needed. Wolters Kluwer Health 2017-05-05 /pmc/articles/PMC5419922/ /pubmed/28471976 http://dx.doi.org/10.1097/MD.0000000000006790 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5700
Jayadevappa, Ravishankar
Chhatre, Sumedha
Wong, Yu-Ning
Wittink, Marsha N.
Cook, Ratna
Morales, Knashawn H.
Vapiwala, Neha
Newman, Diane K.
Guzzo, Thomas
Wein, Alan J.
Malkowicz, Stanley B.
Lee, David I.
Schwartz, Jerome S.
Gallo, Joseph J.
Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)
title Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)
title_full Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)
title_fullStr Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)
title_full_unstemmed Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)
title_short Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)
title_sort comparative effectiveness of prostate cancer treatments for patient-centered outcomes: a systematic review and meta-analysis (prisma compliant)
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419922/
https://www.ncbi.nlm.nih.gov/pubmed/28471976
http://dx.doi.org/10.1097/MD.0000000000006790
work_keys_str_mv AT jayadevapparavishankar comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT chhatresumedha comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT wongyuning comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT wittinkmarshan comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT cookratna comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT moralesknashawnh comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT vapiwalaneha comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT newmandianek comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT guzzothomas comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT weinalanj comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT malkowiczstanleyb comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT leedavidi comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT schwartzjeromes comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant
AT gallojosephj comparativeeffectivenessofprostatecancertreatmentsforpatientcenteredoutcomesasystematicreviewandmetaanalysisprismacompliant